Hedge Fund - Redmile Group
Amicus Therapeutics Inc. (FOLD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $66,457,064 | 4.63% | 7,054,890 | $10.39 |
| 2 | 2024 - Q3 (2024-09-30) | $88,073,603 | 5.18% | 8,246,592 | $10.89 |
| 3 | 2024 - Q2 (2024-06-30) | $105,103,283 | 6.35% | 10,595,089 | $10.26 |
| 4 | 2024 - Q1 (2024-03-31) | $156,170,829 | 5.73% | 13,257,286 | $12.79 |
| 5 | 2023 - Q4 (2023-12-31) | $210,413,875 | 7.52% | 14,828,321 | $11.35 |
| 6 | 2023 - Q3 (2023-09-30) | $206,046,591 | 9.8% | 16,944,621 | $12.90 |
| 7 | 2023 - Q2 (2023-06-30) | $245,761,030 | 9.43% | 19,566,961 | $11.87 |
| 8 | 2023 - Q1 (2023-03-31) | $203,466,688 | 8.82% | 18,346,861 | $12.33 |
| 9 | 2022 - Q4 (2022-12-31) | $247,249,924 | 10.11% | 20,249,789 | $11.26 |
| 10 | 2022 - Q3 (2022-09-30) | $226,748,000 | 8.79% | 21,719,191 | $11.14 |
| 11 | 2022 - Q2 (2022-06-30) | $237,986,000 | 9.08% | 22,158,891 | $8.24 |
| 12 | 2022 - Q1 (2022-03-31) | $211,459,000 | 6.6% | 22,329,386 | $9.38 |
| 13 | 2021 - Q4 (2021-12-31) | $262,371,000 | 5.96% | 22,716,086 | $11.14 |
| 14 | 2021 - Q3 (2021-09-30) | $198,633,000 | 3.46% | 20,799,303 | $10.23 |
| 15 | 2021 - Q2 (2021-06-30) | $200,505,000 | 2.96% | 20,799,303 | $9.76 |
| 16 | 2021 - Q1 (2021-03-31) | $208,607,000 | 2.93% | 21,114,114 | $15.48 |
| 17 | 2020 - Q4 (2020-12-31) | $476,127,000 | 5.76% | 20,620,490 | $20.45 |
| 18 | 2020 - Q3 (2020-09-30) | $325,830,000 | 5.98% | 23,075,807 | $14.57 |
| 19 | 2020 - Q2 (2020-06-30) | $376,166,000 | 6.94% | 24,944,695 | $12.19 |
| 20 | 2020 - Q1 (2020-03-31) | $232,677,000 | 6.52% | 25,181,500 | $9.51 |
| 21 | 2019 - Q4 (2019-12-31) | $245,545,000 | 5.87% | 25,209,964 | $9.15 |
| 22 | 2019 - Q3 (2019-09-30) | $182,777,000 | 6.11% | 22,790,134 | $10.85 |
| 23 | 2019 - Q2 (2019-06-30) | $284,452,000 | 8.04% | 22,792,634 | $12.69 |
| 24 | 2019 - Q1 (2019-03-31) | $266,778,000 | 7.8% | 19,616,062 | $12.22 |
| 25 | 2018 - Q4 (2018-12-31) | $79,736,000 | 3.2% | 8,323,217 | $10.99 |
| 26 | 2018 - Q3 (2018-09-30) | $101,588,000 | 3.12% | 8,402,617 | $13.98 |
| 27 | 2018 - Q2 (2018-06-30) | $164,193,000 | 5.57% | 10,511,732 | $15.12 |
| 28 | 2018 - Q1 (2018-03-31) | $161,509,000 | 6.23% | 10,738,658 | $15.22 |
| 29 | 2017 - Q4 (2017-12-31) | $144,271,000 | 6.27% | 10,025,770 | $13.74 |
| 30 | 2017 - Q3 (2017-09-30) | $166,069,000 | 8.19% | 11,012,561 | $13.23 |
| 31 | 2017 - Q2 (2017-06-30) | $121,282,000 | 7.38% | 12,043,932 | $8.05 |
| 32 | 2017 - Q1 (2017-03-31) | $81,110,000 | 5.26% | 11,375,852 | $6.32 |
| 33 | 2016 - Q4 (2016-12-31) | $61,286,000 | 5.28% | 12,331,130 | $6.92 |
| 34 | 2016 - Q3 (2016-09-30) | $94,361,000 | 7.5% | 12,751,536 | $6.75 |
| 35 | 2016 - Q2 (2016-06-30) | $60,641,000 | 5.79% | 11,106,446 | $6.99 |
| 36 | 2016 - Q1 (2016-03-31) | $90,571,000 | 9.26% | 10,718,420 | $7.08 |
| 37 | 2015 - Q4 (2015-12-31) | $99,722,000 | 7.46% | 10,280,620 | $9.01 |
| 38 | 2015 - Q3 (2015-09-30) | $116,578,000 | 2.67% | 8,332,930 | $15.68 |
| 39 | 2015 - Q2 (2015-06-30) | $89,110,000 | 7.3% | 6,297,523 | $12.02 |
| 40 | 2015 - Q1 (2015-03-31) | $63,455,000 | 5.69% | 5,832,228 | $8.81 |
| 41 | 2014 - Q4 (2014-12-31) | $57,202,000 | 6.22% | 6,875,274 | $6.86 |
| 42 | 2014 - Q3 (2014-09-30) | $33,956,000 | 3.92% | 5,706,906 | $5.24 |
| 43 | 2014 - Q2 (2014-06-30) | $25,552,000 | 3.09% | 7,650,268 | $2.35 |
| 44 | 2014 - Q1 (2014-03-31) | $17,588,000 | 2.08% | 8,496,538 | $2.50 |
| 45 | 2013 - Q4 (2013-12-31) | $20,323,000 | 2.5% | 8,648,087 | $2.20 |
| 46 | 2013 - Q3 (2013-09-30) | $5,739,000 | 0.86% | 2,473,787 | $2.51 |
| 47 | 2013 - Q2 (2013-06-30) | $5,531,000 | 0.97% | 2,373,687 | $3.07 |
| 48 | 2013 - Q1 (2013-03-31) | $6,313,000 | 1.15% | 1,991,490 | $3.38 |
| 49 | 2012 - Q4 (2012-12-31) | $3,006,000 | 0.87% | 1,121,700 | $5.04 |
The displayed share prices are average quarterly stock market prices.